Liquid Biopsies Provide Exosomal MicroRNAs as Biomarkers of the Response to Induction Chemotherapy in High-Risk Neuroblastoma Patients

被引：0
|
作者：
Morini, M. [1 ]
Cangelosi, D. [1 ]
Segalerba, D. [1 ]
Marimpietri, D. [2 ,3 ]
Luksch, R. [4 ]
Catellano, A. [5 ]
Fruci, D. [5 ]
Font de Mora, J. [6 ]
Canete, A. [7 ]
Yanez, Y. [7 ]
Burchill, S. A. [8 ]
Corrias, M. V. [9 ]
Carlini, B. [1 ]
Pezzolo, A. [2 ,3 ]
Schleiermacher, G. [10 ]
Ladenstein, R. [11 ]
Sementa, A. R. [12 ]
Garaventa, A. [13 ]
Eva, A. [1 ]
Varesio, L. [1 ]
机构：
[1] G Gaslini Inst Children, Lab Mol Biol, Genoa, Italy
[2] G Gaslini Inst Children, Stem Cell Lab, Genoa, Italy
[3] G Gaslini Inst Children, Cell Therapy Ctr, Genoa, Italy
[4] Fdn IRCCS Ist Nazl Tumori, Pediat Oncol, Milan, Italy
[5] Bambino Gesu Pediat Hosp, Pediat Hematol & Oncol, Rome, Italy
[6] Inst Invest Sanitaria La Fe, Clin & Translat Res Canc, Valencia, Spain
[7] Hosp Univ & Politecn La Fe, Oncol Pediat, Valencia, Spain
[8] Childrens Canc Res Grp, Leeds Inst Canc & Pathol, Leeds, W Yorkshire, England
[9] G Gaslini Inst Children, Unit Expt Therapy Oncol, Genoa, Italy
[10] Curie Inst, Pediat Oncol, Paris, France
[11] St Anna Childrens Hosp, CCRI, Pediat Oncol, Vienna, Austria
[12] G Gaslini Inst Children, Pathol Unit, Genoa, Italy
[13] G Gaslini Inst Children, Pediat Oncol, Genoa, Italy
来源：
PEDIATRIC BLOOD & CANCER | 2018年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-381
引用
收藏
页码：S266 / S266
页数：1
相关论文
共 50 条
  • [41] Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma
    Kushner, BH
    Kramer, K
    LaQuaglia, MP
    Modak, S
    Yataghene, K
    Cheung, NKV
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (24) : 4888 - 4892
  • [42] Identifying treatment response in high-risk Neuroblastoma
    Roels, F.
    Hero, B.
    Oberthuer, A.
    Berthold, F.
    Fisher, M.
    KLINISCHE PADIATRIE, 2011, 223 (03): : 197 - 197
  • [43] A bridge over troubled water-Extending induction for high-risk neuroblastoma patients with poor end-of-induction response
    Federico, Sara M.
    Cash, Thomas
    CANCER, 2022, 128 (15) : 2880 - 2882
  • [44] Additional Therapies to Improve Metastatic Response to Induction Therapy in Children With High-risk Neuroblastoma
    Schrey, Dominik
    Vaidya, Sucheta J.
    Levine, Daniel
    Pearson, Andrew D. J.
    Moreno, Lucas
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2015, 37 (03) : E150 - E153
  • [45] THE IMPACT OF POST-INDUCTION TREATMENT ON RESPONSE AND OUTCOMES OF PATIENTS WITH HIGH-RISK NEUROBLASTOMA WITH REFRACTORY DISEASE.
    Siddiqui, A.
    Desai, A.
    Cohn, S.
    Gao, G.
    Oppong, A.
    Yuan, C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S52 - S52
  • [46] Diagnostic Potential of Cell-Free and Exosomal MicroRNAs in the Identification of Patients with High-Risk Colorectal Adenomas
    Uratani, Ryo
    Toiyama, Yuji
    Kitajima, Takahito
    Kawamura, Mikio
    Hiro, Junichiro
    Kobayashi, Minako
    Tanaka, Koji
    Inoue, Yasuhiro
    Mohri, Yasuhiko
    Mori, Takao
    Kato, Toshio
    Goel, Ajay
    Kusunoki, Masato
    PLOS ONE, 2016, 11 (10):
  • [47] Efficacy and Safety of Initial Chemotherapy Using Topotecan and Cyclophosphamide for Patients With High-Risk Neuroblastoma
    Miyagawa, Naoyuki
    Sakurai, Yukari
    Keino, Dai
    Yokosuka, Tomoko
    Iwasaki, Fuminori
    Hamanoue, Satoshi
    Shiomi, Masae
    Goto, Shoko
    Nagai, Jyunichi
    Kitagawa, Norihiko
    Nozawa, Kumiko
    Tanaka, Mio
    Tanaka, Yukichi
    Goto, Hiroaki
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S107 - S107
  • [48] The degree of tumor volume reduction during the early phase of induction chemotherapy is an independent prognostic factor in patients with high-risk neuroblastoma
    Yoo, So Young
    Kim, Jung-Sun
    Sung, Ki Woong
    Jeon, Tae Yeon
    Choi, Joon Young
    Moon, Seung Hwan
    Son, Meong Hi
    Lee, Soo Hyun
    Yoo, Keon Hee
    Koo, Hong Hoe
    CANCER, 2013, 119 (03) : 656 - 664
  • [49] Revised antiemetics guidelines and the impact on nutritional status during induction chemotherapy in children with high-risk neuroblastoma
    Carroll, Catherine
    Clinton, Frieda
    Smith, Aisling
    Fox, Aine
    Capra, Michael
    Pears, Jane
    Owens, Cormac
    PEDIATRIC BLOOD & CANCER, 2018, 65 (12)
  • [50] P-Glycoprotein is a resistance mechanism for conventional induction chemotherapy but not ALK inhibitors in high-risk neuroblastoma
    Atkinson, Caroline
    Tactacan, Carole
    Kamili, Alvin
    Saletta, Federica
    Gana, Christine
    Eden, Georgina
    Mayoh, Chelsea
    Lock, Richard
    Norris, Murray
    Haber, Michelle
    Gifford, Andrew
    Trahair, Toby
    Fletcher, Jamie
    CANCER RESEARCH, 2020, 80 (14) : 61 - 61
12345